Axcella Announces Upcoming Investor Conference Presentation
September 29 2020 - 7:58AM
Business Wire
Fireside chat and webcast at H.C. Wainwright
4th Annual NASH Investor Conference to take place on October 5
Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company
pioneering a new approach to treat complex diseases and improve
health using endogenous metabolic modulator (EMM) compositions,
today announced that management will be participating in a fireside
chat at the H.C. Wainwright 4th Annual NASH Investor Conference on
October 5, 2020 at 1:30 p.m. ET.
A live audio webcast of this discussion will be available on the
“Investors & News” section of the company’s website,
www.axcellahealth.com. A replay will also be available on Axcella’s
website for 30 days following the presentation.
Internet Posting of Information
Axcella uses its website, www.axcellahealth.com, as a means of
disclosing material nonpublic information and for complying with
its disclosure obligations under Regulation FD. Such disclosures
will be included on the company’s website in the “Investors &
News” section. Accordingly, investors should monitor this portion
of the company’s website, in addition to its press releases, SEC
filings and public conference calls and webcasts.
About Axcella
Axcella is a clinical-stage biotechnology company pioneering a
new approach to treat complex diseases and improve health using
endogenous metabolic modulator (EMM) compositions. The company’s
product candidates are comprised of EMMs and their derivatives that
are engineered in distinct combinations and ratios to
simultaneously impact multiple biological pathways. Axcella’s
pipeline includes lead therapeutic candidates for non-alcoholic
steatohepatitis (NASH) and the reduction in risk of overt hepatic
encephalopathy (OHE) recurrence. Additional muscle- and
blood-related programs are in earlier-stage development. For more
information, please visit www.axcellahealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200929005131/en/
Jason Fredette jfredette@axcellahealth.com 857.320.2236
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Apr 2023 to Apr 2024